sonically disrupted cells are capable of transmitting sensitization. Their findings have recently been confirmed by Turk (1961) .
Pharmacological Mechanisin of the Local Reaction Very little is known of the local mechanism by which a reaction of the antigen with sensitized cells produces a delayed reaction. Presumably pharmacologically active substances are produced in the course of this reaction, and are responsible for observed delayed vasodilatation effects. The nature of these substances is not known. Some recent evidence suggests that histamine may possibly play a part in delayed reactions. This evidence is derived from two sources. Schayer & Ganley (1959) have shown that histidine decarboxylase activity is increased during the tuberculin reaction and suggested that a protracted formation and release of histamine may be responsible for some of the vascular phenomena observed. Inderbitzin (1956) and Fisher & Cooke (1958) have shown that the histamine content of the skin is increased after application of DNCB and that this increase is considerably greater in an allergic dermatitis than in a primary toxic dermatitis. The increased histamine content is correlated with an increased infiltration of mononuclear cells, but Inderbitzin has calculated that the amount of local accumulated histamine exceeds considerably that which could be present in the infiltrating cells, so that it would seem that some of the increase in histamine content must be attributed to increased histidine decarboxylase activity. Very probably other pharmacologically active substances, such as polypeptides, are also implicated in this reaction, and this would seem to be a fruitful field for further research. The hormones secreted by the anterior pituitary, parathyroid and pancreatic glands are proteins and as such are potentially antigenic. For the purposes of this account, the' early work upon the antigenic properties of these hormones can be disregarded since very impure preparations were then in use. In the past ten years the position has changed rapidly with the introduction of chromatographic, electrophoretic and other techniques for the isolation, identification and analysis of polypeptides and proteins. Experiments have now been carried out with highly purified preparations using experimental animals but, with the exception of insulin, they have not been used for prolonged therapy in human subjects. Our knowledge of the antigenic effects of these pure hormones in man is therefore scanty and will only increase as these preparations become available for clinical use. However, knowledge of their antigenic effects in experimental animals should help to avoid complications which might otherwise arise in clinical practice.
This account is primarily concerned with the results of experimental work designed to evoke and study antibody production in animals. The hormones used have included three whose structures are known (corticotrophin, glucagon and insulin), two which have been purified but whose structures have not yet been defined (somatotrophin and mammotrophin) and others which have yet to be obtained in homogeneous forms (thyrotrophin and gonadotrophins).
Antibody Production
The only pure hormone which has been used extensively for the treatment of human disease is insulin. Within a few months of the commencement of insulin therapy, low concentrations of insulin antibodies can be detected in the blood and in a few patients who become insulin resistant their concentration may rise sharply (Berson & Yalow 1958) . Repeated injections of insulin suspended in oily adjuvant mixtures have also been given to guinea-pigs, rabbits, horses and sheep (Wright 1960) . The sera of these animals have also been shown to contain antibodies which often appear in high concentration. This method was therefore adopted by Read & Stone (1958) to obtain antibodies to somatotrophin from rabbits and used by subsequent workers to get sera containing antibodies to corticotrophin, mammotrophin, thyrotrophin, glucagon and gonadotrophins. It is with the sera of these treated animals that this account is concerned.
Antibody Detection
Reactions between the purified hormone antigens and their corresponding antibodies in the sera of treated animals have been demonstrated by conventional immunological methods. In addition it has been shown that some of these sera will inhibit the biological effects of the corresponding hormones in vivo or in vitro.
(a) Immunological reactions: At first, conventional immunological methods (precipitation, complement fixation, &c.) were used in attempts to demonstrate insulin antibodies. As the results were inconsistent and confusing other methods were sought. Two were developed and these have been used to detect the antibodies of other hormones.
First, Arquilla & Stavitsky (1956a) showed that the serum of insulin-treated rabbits and of some human diabetics would agglutinate sheep red cells coated with insulin. Since then agglutination of red cells coated with the homologous hormone has been demonstrated with serum of rabbits treated with corticotrophin (Fishman et al. 1959 ), somatotrophin (Read & Stone 1958) , mammotrophin (Levy & Sampliner 1961) , chorionic gonadotrophin (Wide & Gemzell 1960), and thyrotrophin (Cline et al. 1960) . In each case agglutination is inhibited by prior addition of the homologous hormone to the serum and is not produced by normal serum.
The second method was devised by Berson and his co-workers (Berson et al. 1956 , Berson & Yalow 1959a . Insulin labelled with iodine-131 is added to human serum and the mixture submitted to chromato-electrophoresis on filter paper. The serum of patients who have received insulin treatment for any length of time will bind the labelled hormone in the 'inter y-3' zone of the serum proteins, whereas insulin added to the serum of subjects who have not received any hormone therapy remains fixed at the point of application to the paper. Comparable results are obtained with the serum of insulin-treated guinea-pigs and rabbits (Morse 1959 ). More recently it has been shown that 1311-labelled glucagon is also bound by the globulins in the serum of rabbits treated with that pancreatic hormone (Unger et al. 1961 ). In each case unlabelled hormone added in excess before electrophoresis displaces the labelled hormone which would otherwise become bound by the globulins.
These two methods were originally devised for the detection of insulin antibodies which do not usually precipitate the antigen; horse anti-insulin serum is a notable exception (Moloney & Aprile 1959) . However, antigen precipitation is caused by the sera of rabbits treated with somatotrophin (Hayashida & Li 1958 ), thyrotrophin (Werner et al. 1961 ) and chorionic gonadotrophin (Butt et al. 1961 ). These hormonal antisera have therefore been studied by gel-diffusion techniques.
(b) Biological methods: The hypoglycwmic effect of insulin in mice (Moloney & Goldsmith 1957) and its stimulant effect upon glucose consumption by the isolated rat diaphragm (Wright 1959) are inhibited by the sera ofinsulin-treated animals. Likewise the sera of rabbits treated with somatotrophin (Hayashida & Li 1958) , thyrotrophin (Cline et al. 1960 ) and with gonadotrophins (Butt et al. 1961 ) will inhibit the actions of these hormones in suitable experimental animals. Thus, for example, the serum of rabbits treated with somatotrophin will inhibit the growth normally stimulated by this hormone in the tibial epiphyseal cartilage of the hypophysectomized rat.
These examples serve to show that treatment of animals with purified protein hormones evokes antibodies which will combine with or biologically inactivate the homologous antigens.
Specificity ofHormone Antibodies
The hormone antibodies are apparently hormone specific but most of them, like those of insulin, are probably not species specific. Insulin, for example, is the only protein which has been shown to inhibit the agglutination of insulin-coated red cells by rabbit anti-insulin serum (Arquilla & Stavitsky 1956b ). On the other hand, the sera of insulin-treated animals will inhibit the effects produced in vivo (Moloney & Goldsmith 1957) and in vitro (Wright 1959) by insulin obtained from a number of animals. Lowell (1944) has, however, described the case of an insulin-resistant diabetic who did not respond to intravenous bovine insulin but who became hypoglyctmic following the injection of human insulin. Also Yalow & Berson (1960a) claim that the serum of guinea-pigs treated with bovine insulin will bind the homologous hormone much more firmly than human insulin; Grodsky & Forsham (1961) disagree. The majority of the evidence (Wright 1960), however, does suggest that insulin antibodies are not species specific but it may be, as Berson & Yalow (1959b) point out, that biological methods of assay are too insensitive to detect small differences in insulin-binding capacity. Present evidence, which is still not complete, also suggests that, with the exception of somatotrophin, all the other hormones evoke antibodies which are not species specific. The antibody to human somatotrophin, however, will not precipitate or inhibit the biological action of the bovine hormone though it will react with the homologous antigen or with monkey somatotrophin (Read & Bryan 1960) .
Discussion
Since most of these observations have been made in the past five or ten years our knowledge of the hormone antibodies is obviously still in its infancy. Yet certain practical applications have been found for these immunological techniques and light has been thrown upon some of the perplexing clinical problems associated with hormonal therapy in human patients. These require some consideration at this point.
Biological methods for the assay of protein hormones in blood have not proved very satisfactory. In a recent review of the methods of plasmainsulin assay (Vallance-Owen & Wright 1960) it was pointed out that the development of simpler, more specific and more precise methods of assay might increase the clinical usefulness of plasmainsulin assays. At about the same time Yalow & Berson (1960a, b) introduced an immunoassay; they compared the abilities of human plasma and human insulin to displace labelled bovine insulin from its binding site in the serum globulins of insulin-treated guinea-pigs. This new method has the virtues of greater precision and specificity. They showed that the levels of insulin in the plasma of normal human subjects are of the same order as the lowest estimates obtained by biological methods. A similar method has now been developed and used to estimate the glucagon content of the plasma of dogs under various experimental conditions (Unger et al. 1961 ). The only other protein hormone which has been assayed successfully in blood by an immunochemical method is somatotrophin. Two techniques were develo,ped based on the observations that agglutination of suitably coated red cells (Read & Stone 1958 ) and precipitation of the homologous hormone (Read & Bryan 1960) by the serum of rabbits treated with human somatotrophin are inhibited by human serum. With these assay methods it has been shown that somatotrophin levels are elevated in acromegaly and low in hypopituitarism (Read 1960 , Boucher & Mason 1961 , Ehrlich & Randle 1961 , Hartog & Frazer 1961 , Read & Bryan 1960 . Using a hkmagglutination technique, chorionic gonadotrophin in the urine of pregnant and normal women has been assayed but there is some doubt in this case about the specificity of the method (Wide & Gemzell 1960 , Butt et al. 1961 . Unlike the biological assay methods, these immunoassay techniques can only be used to detect and estimate material which is immunologically identical with or very closely related to the hormone used for reference, but which may not have the same biological properties. It is possible, for instance, that a tumour may be secreting a biologically active substance which is immunologically distinct from the normal hormone or vice versa. For this reason the results of such immunoassays will have to be interpreted with caution. Some light has been thrown on two clinical problems by the information which has emerged from these chemical and immunological investigations. First, the work of Sanger and his coworkers (Sanger 1960) has shown that the structures of insulin molecules produced by the ox and the pig are very similar to that of human insulin. It is not surprising to find, therefore, that these insulins which are extensively used in Europe and America are only weakly antigenic in man. The problem which remains to be solved is the role of insulin antibodies in those few diabetics who become resistant to insulin therapy; the fact that high concentrations of antibodies are often present in the serum is not the only factor (Berson & Yalow 1958) . Secondly, there are marked chemical and immunological differences between bovine somatotrophin and either monkey or human somatotrophin (Raben 1959 ). Bovine somatotrophin is ineffective biologically in man or in the monkey (Knobil & Greep 1959) whereas the human hormone is active in both and all three will stimulate growth of the tibial epiphyseal cartilage of the rat. To explain this, Li (1957) has suggested that the rat, unlike man, is able to remove part of the larger molecule of the bovine hormone and so bare its active 'core'. Whether this is the correct explanation or not, it is now plain that the failure of the bovine hormone to exert an effect in man is not due to any antigenic effect of this hormone. Whether other heterologous hormones will induce hormone resistance when administered in pure forms to human patients is not yet known but it may be significant that when they are administered to animals without any adjuvant their antigenic properties are much weaker. There is some reason to hope, therefore, that increased use of purified hormones in the treatment of patients will not lead to the widespread appearance of hormone resistance.
Lastly it should be mentioned that, with one exception, no hormone antibody has been produced which will neutralize and inactivate an endogenously secreted hormone. The exception is the antibody in the serum of guinea-pigs treated with bovine insulin which, on injection into a variety of experimental aninials, will induce hyperglycemia and diabetes (Armin et al. 1961 ).
Should others be produced with comparable properties it may then be possible to study more states of pure hormone deficiency in experimental animals and it is conceivable that new methods could be devised to treat cases with conditions associated with excessive hormone secretion. , referring to a suggestion made by Professor Rosenheim, that patients who were allergic or who had asthma were more likely to get drug reactions, said that in a group of tuberculous patients receiving antituberculous drugs for the first time a considerable number developed allergic reactions; it was not, however, possible to say that these were allergic subjects and there was nothing in their past history, even in those who developed reactions both to streptomycin and to PAS simultaneously, of asthma or other allergic diseases. In studying the same group some effects of age and sex had been noted. As far as age was concerned, reactions to these drugs were very rare in children up to the age of 15. As far as sex was concerned, they were much more common in females than in males.
The number of reactions to two drugs given simultaneously was something like five times as high as would have been expected.
Mr Davies had said that the incidence of drug reaction was very low, but in the group of patients mentionedwho were given large doses of drugs every day over a periodthe incidence was about 8 % for both streptomycin and for PAS, which was quite a high figure.
Dr J R Marrack (Cambridge) asked whether Professor Schild knew of any pharmacologically active substance that produced a histological picture like that of a delayed reaction.
Professor H 0 Schild, in reply, said that high concentrates of PC and DNCB painted on the skin produced reactions which were macroscopically very similar to those produced by much lower concentrations of the same substances in a sensitized animal. However, the histological picture in the two cases was quite different. Fisher & Cooke (1958, J. Allergy 29, 411) had shown that the primary toxic reaction was characterized by necrosis of epidermal cells accompanied by scant extravasation of polymorphonuclear and mononuclear cells, while the lesion of the allergic response was characterized by massive extravasation of mononuclear cells. He did nct know of any primary toxic reaction produced by a drug in which this massive mononuclear extravasation occurred. Dr H R Vickers (Oxford) said he had been very interested in the question of penicillin sensitization, particularly in regard to penicillin sensitization of the skin. He and his colleagues had had a group of patients some time ago who were shown, fairly conclusively, to have a rash which was kept active by the penicillin content in milk. Dr Vickers asked Mr Davies how long penicillenic acid persisted in a solutionpresumably it occurred in penicillin in milk which had been contaminated by penicillin given to cowsand whether that persisted for any length of time. If so, it might be expected that in the future quite a number of patients would be seen who had developed a rash or had a persistent rash and who had previously been sensitized by an application of penicillin.
Professor Schild had seemed to dismiss the difficult problem of the establishment of epidermal sensitization, and many workers had felt that sensitization of the skin could only be produced by contact with the sensitizer and the skin. But Professor Schild had told of experiments where lymph nodes had been used to establish epidermal sensitization. Dr Vickers asked Professor Schild if he could be quite sure that those lymph nodes did not contain proteins of keratin or a keratin precursor because, if so, it would still be felt that contact sensitization could only be established really by contact with the skin.
Mr G E Davies said that penicillenic acid was very unstable. The more acid the solution was, the more stable the penicillenic acid.
Professor Schild said he would have thought that Seeberg's experiments had shown clearly that it was not necessary to inject the hapten into the skin. He had injected it into lymph nodes under comple! e avoidance of the skin and yet obtained generalized skin contact sensitization. Nevertheless, Professor Schild thought that it could not be excluded that even when injected into a lymph gland the hapten might combine in the first instance with a fibrous protein, as suggested bv Mayer. On the other hand, Eisen's hypothesis seemed to imply that the essential condition for the establishment of delayed hypersensitivity of the skin was the capacity of lymph-node cells to take up tlI,Q antigen.
